The package leaflets enclosed with all batches of Zemplar 5 µg/ml, solution for injection currently on the Swiss market contain a translation error in the French text under ‘Dosage/Administration’.
AbbVie is working on correcting the package leaflet. Until the corrected version is available, the letter will be included with all shipments of Zemplar 5 µg/ml, solution for injection.
For further information, please refer to the company's information letter.